Amedeo Smart

Free Medical Literature Service

 

Amedeo

Kidney Transplantation
  Free Subscription

Articles published in
Kidney Int
    October 2026
  1. CHEN C, Elias C, Keyser M, Wellekens K, et al
    Early acute T cell-mediated rejection and kidney allograft outcomes.
    Kidney Int. 2026;110:946-963.
    >> Share

  2. LEBRAUD E, Aubert O, Aouni L, Garcia V, et al
    Non-HLA antibodies worsen the histological phenotype and prognosis of antibody mediated rejection in kidney allografts.
    Kidney Int. 2026;110:930-945.
    >> Share

    September 2026
  3. MAK ML, Murphy JM, Mathews JA, Su S, et al
    Donor and recipient immune programs underlying delayed graft function in kidney transplantation revealed by temporal single-cell profiling.
    Kidney Int. 2026 Sep 22:S0085-2538(26)00787-8. doi: 10.1016/j.kint.2026.
    >> Share

    August 2026
  4. BALADO-SIMO P, Morgado-Carrasco D
    Eruptive Disseminated Porokeratosis After Kidney Transplantation.
    Kidney Int. 2026 Aug 21:S0085-2538(26)00701-5. doi: 10.1016/j.kint.2026.
    >> Share

  5. USUREAU C, Siemowski J, Anglicheau D, Leon J, et al
    Optimizing risk-benefit in highly sensitized kidney recipient antigen delisting increasing donor access.
    Kidney Int. 2026;110:477-482.
    >> Share

    July 2026
  6. DRASCH T, Mayer KA, Bohmig GA, Akifova A, et al
    A multicenter registry study of the CD38 antibody daratumumab for the treatment of microvascular inflammation following kidney transplantation.
    Kidney Int. 2026 Jul 23:S0085-2538(26)00604-6. doi: 10.1016/j.kint.2026.
    >> Share

  7. GAUTHIER PT, Halloran PF
    A potential role for effector T cells with Fc receptors in kidney transplant antibody-mediated rejection.
    Kidney Int. 2026;110:29-32.
    >> Share

  8. GATELY R, Sabanayagam D, Lim WH, Zhu L, et al
    Advances in survival analyses: machine learning methods and model comparison.
    Kidney Int. 2026;110:78-88.
    >> Share

    June 2026
  9. KURZHAGEN JT, Laqua W, Schiffer M, Grieshaber-Bouyer R, et al
    T-cell engagers mediate deep cell depletion beyond autoimmunity.
    Kidney Int. 2026;109:1081-1084.
    >> Share

  10. GATELY R, Wong G, Teixeira-Pinto A
    Techniques to predict survival outcomes in nephrology: basics and traditional methods.
    Kidney Int. 2026;109:1137-1147.
    >> Share

  11. LEON J, Aubert O, Devriese M, Alameda F, et al
    B-cell maturation antigen-Targeted T-cell Engager Therapy Combined with B-cell Depletion for Treatment of Refractory HLA Sensitization.
    Kidney Int. 2026;109:1148-1154.
    >> Share

    April 2026
  12. VAULET T, Lamarthee B, Callemeyn J, Koshy P, et al
    Intragraft clonal expansion of cytotoxic CD8(+) and CD4(+) T cells in antibody-mediated kidney transplant rejection.
    Kidney Int. 2026 Apr 23:S0085-2538(26)00302-9. doi: 10.1016/j.kint.2026.
    >> Share

  13. PERKINS GB, Naesens M
    Nobel prize-winning Treg cells in autoimmune kidney diseases and transplantation.
    Kidney Int. 2026;109:624-629.
    >> Share

  14. BACCHETTA J, Acquaviva-Bourdain C, Abid N, Sellier Leclerc AL, et al
    Primary hyperoxaluria(s): from trials to real-life data and pipeline therapies.
    Kidney Int. 2026;109:661-670.
    >> Share

    March 2026
  15. SCHOTT C, Relouw S, Arnaldi M, Baker C, et al
    Genetic testing in kidney transplantation and living kidney donor risk assessment.
    Kidney Int. 2026 Mar 26:S0085-2538(26)00234-6. doi: 10.1016/j.kint.2026.
    >> Share

  16. SAHARA H, Shimizu A
    Pathologic diagnosis incorporating molecular monitoring highlights new pathophysiological mechanisms in kidney xenotransplantation.
    Kidney Int. 2026;109:433-436.
    >> Share

  17. VANHOLDER R, Abdellatif D, Soares Dos Santos AC Jr, Correa-Rotter R, et al
    Kidney health for all: caring for people, protecting the planet.
    Kidney Int. 2026;109:408-417.
    >> Share

  18. ROSALES IA, Giarraputo A, Trivin-Avillach C, Karadagi A, et al
    Mechanistic insights from transcript analysis of long-term pig to non-human primate kidney xenografts.
    Kidney Int. 2026;109:506-524.
    >> Share

    January 2026
  19. KUPSCH C, Tsou S, Martin F, Wolff von Gudenberg R, et al
    Eligibility, Timing and Organ Quality: Indications and Outcomes of Kidney Transplantation in Older Patients.
    Kidney Int. 2026 Jan 21:S0085-2538(26)00052-9. doi: 10.1016/j.kint.2025.
    >> Share

  20. GIARRAPUTO A, Metzger E, Brousaides N, Marcin J, et al
    Single-cell spatial transcriptomics reveal intraglomerular cell activation and ligand-receptor relationships in chronic, active antibody mediated rejection.
    Kidney Int. 2026;109:196-210.
    >> Share

    December 2025
  21. DESENCLOS J, Halimi C, Vidal-Petiot E, Motiejunaite J, et al
    Parathyroid hormone suppression profiles following oral calcium challenge in kidney transplant recipients.
    Kidney Int. 2025 Dec 26:S0085-2538(25)01010-5. doi: 10.1016/j.kint.2025.
    >> Share

  22. GOMPERS A, Harding JL
    Improving transplant access and outcomes for women-the importance of the patient perspective.
    Kidney Int. 2025;108:991-993.
    >> Share

  23. SHEN Q, Zhu T, Yan S, Wang Y, et al
    Macrophages mediate acute kidney allograft rejection via a toll-like receptor 4-dependent mechanism.
    Kidney Int. 2025;108:1105-1122.
    >> Share

    November 2025
  24. COZZI E
    Delisting of HLA antigens as a possible strategy to enable transplantation in highly sensitized patients with a cPRA >/= 99.9.
    Kidney Int. 2025;108:748-751.
    >> Share

  25. ROBERTSON H, Perkins GB
    Adopting a wider view: factoring blood, biopsy, and urine into kidney transplant outcomes.
    Kidney Int. 2025;108:745-748.
    >> Share

  26. ARNOUX G, Serre J, Verissimo T, Tihy M, et al
    Integrated spatial and functional metabolic profiling identified the thick ascending limb as a mitochondrial vulnerability hub in acute kidney injury.
    Kidney Int. 2025;108:866-882.
    >> Share

    October 2025
  27. RICO-FONTALVO J, Ciudin A, Correa-Rotter R, Diaz-Crespo FJ, et al
    S.E.N., SLANH, and SEEDO consensus report on obesity-related kidney disease: proposal for a new classification.
    Kidney Int. 2025;108:572-583.
    >> Share

  28. EDER M, Kainz A, Omic H, Aigner C, et al
    A systematic literature review and meta-analysis evaluated modifiable risk factors for the development of BK polyoma virus-associated complications.
    Kidney Int. 2025;108:669-685.
    >> Share

    September 2025
  29. LANGE J, Queissert F, Pavenstadt H, Al-Itaibi R, et al
    An unexpected focus of infection after kidney transplantation.
    Kidney Int. 2025;108:504.
    >> Share

  30. BOHMIG GA, Budde K
    Intravenous immunoglobulin for chronic active antibody-mediated rejection: a signal of hope in an evolving field.
    Kidney Int. 2025;108:351-354.
    >> Share

    August 2025
  31. LADHANI M, Jaure A, Davidson B, Barday Z, et al
    A multinational qualitative study examined the perspectives and experiences of women with a kidney transplant on access to healthcare.
    Kidney Int. 2025 Aug 25:S0085-2538(25)00658-1. doi: 10.1016/j.kint.2025.
    >> Share

  32. REESE PP, Mohan S, Schaubel DE, Forbes R, et al
    Low prevalence of glomerulonephritis in transplanted kidneys from deceased donors with active hepatitis C virus infection.
    Kidney Int. 2025 Aug 22:S0085-2538(25)00657-X. doi: 10.1016/j.kint.2025.
    >> Share

  33. KUMAR T, Tiwari V, Gupta A, Rao S, et al
    Cutaneous histoplasmosis in a patient with a kidney transplant.
    Kidney Int. 2025;108:333.
    >> Share

    July 2025
  34. MURAKAMI N, Blosser CD, Webber AB, Gupta G, et al
    Management recommendations for kidney transplantation in patients with plasma cell dyscrasia.
    Kidney Int. 2025 Jul 28:S0085-2538(25)00576-9. doi: 10.1016/j.kint.2025.
    >> Share

  35. TINEL C, Varin A, Anglicheau D, Callemeyn J, et al
    Multi-omic factor analyses uncovered cross-compartment complexity of biological processes in kidney transplantation.
    Kidney Int. 2025 Jul 7:S0085-2538(25)00512-5. doi: 10.1016/j.kint.2025.
    >> Share

  36. ZHANG H, Sabiu G, Jung S, Podesta MA, et al
    Targeted delivery of IL-21 neutralizing nanotherapeutics to lymph nodes and kidney allografts attenuates B cell alloimmunity.
    Kidney Int. 2025;108:48-56.
    >> Share

    June 2025
  37. CUCCHIARI D, Mancebo-Sierra E, Caro JL, Meneghini M, et al
    A multicenter prospective cohort study evaluating impact of an active delisting strategy to enable kidney transplantation in wait-listed candidates with calculated Panel Reactive Antibody >/= 99.9.
    Kidney Int. 2025 Jun 6:S0085-2538(25)00427-2. doi: 10.1016/j.kint.2025.
    >> Share

  38. RIZZOLO K, Villegas L, Cervantes L
    The national landscape of kidney transplantation for undocumented immigrants: advancing kidney transplantation equity.
    Kidney Int. 2025;107:976-979.
    >> Share

  39. VAN LOON E, Gillard P, Naesens M
    SGLT2 inhibitors fulfill their expectations in diabetic kidney transplant recipients.
    Kidney Int. 2025;107:966-969.
    >> Share

  40. NORDHEIM E, Hovd M, Dahle DO
    Kidney transplantation and hyperbaric oxygen treatment for calciphylaxis.
    Kidney Int. 2025;107:1113.
    >> Share

  41. MON-WEI YU S, Choi JY, Kady J, De Cos M, et al
    Transplantation of human kidney organoids elicited a robust allogeneic response in a humanized mouse model.
    Kidney Int. 2025;107:1011-1016.
    >> Share

  42. KINOSHITA Y, Kobayashi E, Matsui K, Inage Y, et al
    Life-supporting functional kidney replacement by integration of embryonic metanephros-bladder composite tissue transplants.
    Kidney Int. 2025;107:1051-1063.
    >> Share

    May 2025
  43. MULLEY WR, Tharmaraj D, Polkinghorne KR, Tesch GH, et al
    A randomized controlled trial of intravenous immunoglobulin vs standard of care for the treatment of chronic active antibody-mediated rejection in kidney transplant recipients.
    Kidney Int. 2025 May 22:S0085-2538(25)00406-5. doi: 10.1016/j.kint.2025.
    >> Share

  44. HABBIG S, Debiec H, Chedik M, Stippel DL, et al
    Anti-nephrin antibodies guide living donor kidney transplantation in a pediatric patient with primary focal segmental glomerular sclerosis.
    Kidney Int. 2025 May 16:S0085-2538(25)00393-X. doi: 10.1016/j.kint.2025.
    >> Share

  45. SEIF N, Bloom RD
    Using donor-derived cell-free DNA in kidney transplant patients: this jury needs more evidence.
    Kidney Int. 2025;107:796-799.
    >> Share

  46. BUDDE K, Osmanodja B, Schrezenmeier E, Halleck F, et al
    Clinical utility of donor-derived cell-free DNA testing for kidney transplant monitoring in selected patients.
    Kidney Int. 2025;107:792-796.
    >> Share

    March 2025
  47. RAYNAUD M, Bakker SJL, Bentall AJ, Loupy A, et al
    Glomerular filtration rate equations in kidney transplant recipients: the need for specificity.
    Kidney Int. 2025;107:568.
    >> Share

    February 2025
  48. MENON G, Metoyer GT, Li Y, Chen Y, et al
    A national registry study evaluated the landscape of kidney transplantation among presumed unauthorized immigrants in the United States.
    Kidney Int. 2025 Feb 14:S0085-2538(25)00088-2. doi: 10.1016/j.kint.2025.
    >> Share

  49. SELCUK ZD, Atas DB, Menetlioglu G, Dericioglu V, et al
    Kaposi sarcoma and its rare presentation in a kidney transplant recipient.
    Kidney Int. 2025;107:363.
    >> Share

  50. HIRSCH HH
    Can you have a cake and eat it? Comparing reducing mycophenolate versus switching to everolimus for kidney transplants with new-onset BKPyV-DNAemia.
    Kidney Int. 2025;107:230-233.
    >> Share

    January 2025
  51. HERRMANN SM, Abudayyeh A, Gupta S, Gudsoorkar P, et al
    Diagnosis and management of immune checkpoint inhibitor-associated nephrotoxicity: a position statement from the American Society of Onco-nephrology.
    Kidney Int. 2025;107:21-32.
    >> Share

    December 2024
  52. ZANONI F, Obayemi JE, Gandla D, Castellano G, et al
    Emerging Role of Genetics in Kidney Transplantation.
    Kidney Int. 2024 Dec 20:S0085-2538(24)00913-X. doi: 10.1016/j.kint.2024.
    >> Share

  53. KAVANAGH D, Ardissino G, Brocklebank V, Bouwmeester RN, et al
    Outcomes from the International Society of Nephrology Hemolytic Uremic Syndromes International Forum.
    Kidney Int. 2024;106:1038-1050.
    >> Share

    November 2024
  54. VAN DEN BERG CW, Dumas SJ, Little MH, Rabelink TJ, et al
    Challenges in maturation and integration of kidney organoids for stem cell-based renal replacement therapy.
    Kidney Int. 2024 Nov 19:S0085-2538(24)00806-8. doi: 10.1016/j.kint.2024.
    >> Share

  55. GOUTAUDIER V, Danger R, Catar RA, Racape M, et al
    Evaluation of non-invasive biomarkers of kidney allograft rejection in a prospective multicenter unselected cohort study (EU-TRAIN).
    Kidney Int. 2024;106:943-960.
    >> Share

    October 2024
  56. CAILLARD S, Meyer N, Solis M, Bertrand D, et al
    Insights from the BKEVER Trial comparing everolimus versus mycophenolate mofetil for BK Polyomavirus infection in kidney transplant recipients.
    Kidney Int. 2024 Oct 25:S0085-2538(24)00730-0. doi: 10.1016/j.kint.2024.
    >> Share

  57. HATTORI M
    Anti-nephrin autoantibodies: novel predictors of post-transplant recurrence of focal segmental glomerular sclerosis.
    Kidney Int. 2024;106:570-572.
    >> Share

  58. BATAL I, Watts AJB, Gibier JB, Hamroun A, et al
    Pre-transplant anti-nephrin antibodies are specific predictors of recurrent diffuse podocytopathy in the kidney allograft.
    Kidney Int. 2024;106:749-752.
    >> Share

  59. AHMADI A, Yu J, Loza JE, Howard BC, et al
    Deceased donor kidney function and branched chain amino acid metabolism during ex vivo normothermic perfusion.
    Kidney Int. 2024;106:712-722.
    >> Share

  60. HEERSPINK HJL, Eddington D, Chaudhari J, Estacio R, et al
    A meta-analysis of randomized controlled clinical trials for implications of acute treatment effects on glomerular filtration rate for long-term kidney protection.
    Kidney Int. 2024;106:688-698.
    >> Share

    September 2024
  61. AGARWAL KA, Adingwupu OM, Tighiouart H, Miao S, et al
    Estimating GFR in Kidney Transplant Recipients: Considerations for Selecting Equations.
    Kidney Int. 2024 Sep 9:S0085-2538(24)00632-X. doi: 10.1016/j.kint.2024.
    >> Share

  62. SCHAENMAN JM
    The adaptive and innate immune systems coordinate for successful control of CMV infection.
    Kidney Int. 2024;106:364-366.
    >> Share

  63. CLEENDERS E, Coemans M, Meziyerh S, Callemeyn J, et al
    An observational cohort study examined the change point of kidney function stabilization in the initial period after transplantation.
    Kidney Int. 2024;106:508-521.
    >> Share

  64. PERKINS GB, Zuiani JD, Coates PT
    The innate immune cells at the heart of kidney allograft rejection.
    Kidney Int. 2024;106:348-350.
    >> Share

    August 2024
  65. WILLICOMBE M, Roberts DJ
    TRANSFUSION-INDUCED HLA SENSITISATION IN WAITLIST PATIENTS AND KIDNEY TRANSPLANT RECIPIENTS.
    Kidney Int. 2024 Aug 22:S0085-2538(24)00573-8. doi: 10.1016/j.kint.2024.
    >> Share

  66. ZHANG P, Sun C, Mo S, Hu C, et al
    Salvaging donated kidneys from prolonged warm ischemia during ex vivo hypothermic oxygenated perfusion.
    Kidney Int. 2024;106:273-290.
    >> Share

  67. ZHANG R, Trotter PB, McCaffrey J, Fitzroy R, et al
    Assessment of biological organ age using molecular pathology in pre-transplant kidney biopsies.
    Kidney Int. 2024;106:302-316.
    >> Share

    July 2024
  68. JOHNSON RJ, Mandell BF, Schlessinger N, Mount DB, et al
    Controversies and practical management of patients with gout and chronic kidney disease.
    Kidney Int. 2024 Jul 19:S0085-2538(24)00473-3. doi: 10.1016/j.kint.2024.
    >> Share

  69. CORNEC-LE GALL E, Mallett AJ
    Genomics in the kidney transplant clinic: the future standard of care?
    Kidney Int. 2024;106:18-20.
    >> Share

  70. RIOS IP, Nguyen CHL, Misra SS, Ryan MS, et al
    Foscarnet-induced nephropathy in a kidney transplant recipient.
    Kidney Int. 2024;106:156.
    >> Share

  71. ASOWATA EO, Romoli S, Sargeant R, Tan JY, et al
    Multi-omics and imaging mass cytometry characterization of human kidneys to identify pathways and phenotypes associated with impaired kidney function.
    Kidney Int. 2024;106:85-97.
    >> Share

  72. WONG G, Guha C, Mallitt KA, van Zwieten A, et al
    The randomized controlled trial (NAVKIDS2) of a patient navigator program created for children with chronic kidney disease.
    Kidney Int. 2024 Jul 1:S0085-2538(24)00450-2. doi: 10.1016/j.kint.2024.
    >> Share

    June 2024
  73. TANTISATTAMO E
    Implementation science: a tool to narrow know-do gap and widen equity in kidney diseases and transplantation.
    Kidney Int. 2024;105:1322-1323.
    >> Share

    May 2024
  74. KNECHTLE SJ, Ladowski JM, Kwun J
    A pig kidney supporting human physiology.
    Kidney Int. 2024;105:921-922.
    >> Share

    April 2024
  75. DONADEU L, Jouve T, Bin S, Hartzell S, et al
    High-dimensional Mass Cytometry identified circulating Natural Killer T-cell subsets associated with protection from Cytomegalovirus infection in kidney transplant recipients.
    Kidney Int. 2024 Apr 27:S0085-2538(24)00310-7. doi: 10.1016/j.kint.2024.
    >> Share

  76. CORNELL LD, Shankaranarayanan D, Rodriguez PS, Damgard SE, et al
    Sickle cell disease in the kidney transplant.
    Kidney Int. 2024;105:892.
    >> Share

  77. LEVIN A, Ahmed SB, Carrero JJ, Foster B, et al
    Executive summary of the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease: known knowns and known unknowns.
    Kidney Int. 2024;105:684-701.
    >> Share

  78. CALLEMEYN J, Naesens M
    Back to the future: the uncharted role of T cells in chronic and unexplained microvascular inflammation.
    Kidney Int. 2024;105:669-671.
    >> Share

  79. CRISTOFERI I, Varol H, van Baardwijk M, Rahiem L, et al
    Multiomic profiling of transplant glomerulopathy reveals a novel T-cell dominant subclass.
    Kidney Int. 2024;105:812-823.
    >> Share

    March 2024
  80. MA BM, Elefant N, Tedesco M, Bogyo K, et al
    Genetic testing in kidney transplantation helped develop a morbidity gene panel for evaluation of kidney transplant recipients.
    Kidney Int. 2024 Mar 21:S0085-2538(24)00188-1. doi: 10.1016/j.kint.2024.
    >> Share

  81. JARMI T, Luo Y, Attieh RM, Qie Y, et al
    CAR T-cell therapy-paving the way for sensitized kidney transplant patients.
    Kidney Int. 2024 Mar 21:S0085-2538(24)00159-5. doi: 10.1016/j.kint.2024.
    >> Share

  82. PALMER ND, Freedman BI
    APOL1-mediated and Mendelian forms of "heretofore" idiopathic collapsing glomerulopathy: lessons from Brazil.
    Kidney Int. 2024;105:437-439.
    >> Share

  83. RAINA R, Jothi S, Haffner D, Somers M, et al
    Post-transplant recurrence of focal segmental glomerular sclerosis: consensus statements.
    Kidney Int. 2024;105:450-463.
    >> Share

  84. SHIRAI Y, Miura K, Ishizuka K, Ando T, et al
    A multi-institutional study found a possible role of anti-nephrin antibodies in post-transplant focal segmental glomerulosclerosis recurrence.
    Kidney Int. 2024;105:608-617.
    >> Share

  85. GILL JS, Chadban SJ
    Pretransplant screening for coronary artery disease: data are required before practice change.
    Kidney Int. 2024;105:470-472.
    >> Share

    February 2024
  86. VENKATARAMAN K, McTaggart SJ, Collins MG
    Choosing fluids to reduce the risks of acute electrolyte disturbances in children after a kidney transplant.
    Kidney Int. 2024;105:247-250.
    >> Share

  87. HAAS M
    Improving frozen section evaluation of procurement donor kidney biopsies and reducing the discard rate: a promising role for artificial intelligence.
    Kidney Int. 2024;105:240-242.
    >> Share

  88. SHAH Y, Yang H, Mueller FB, Li C, et al
    Transcriptomic signatures of chronic active antibody-mediated rejection deciphered by RNA sequencing of human kidney allografts.
    Kidney Int. 2024;105:347-363.
    >> Share

  89. LOBAN K, Fadel E, Nugus P, Przybylak-Brouillard A, et al
    Living kidney donors' health care needs, experiences, and perspectives across their entire donation trajectory: a semistructured, in-depth interview study.
    Kidney Int. 2024;105:251-258.
    >> Share

  90. YI Z, Xi C, Menon MC, Cravedi P, et al
    A large-scale retrospective study enabled deep-learning based pathological assessment of frozen procurement kidney biopsies to predict graft loss and guide organ utilization.
    Kidney Int. 2024;105:281-292.
    >> Share

    January 2024
  91. LUO X, Knechtle S
    The T-cell environment: may the regulatory force be with you.
    Kidney Int. 2024;105:20-22.
    >> Share

    November 2023
  92. HARRISON TG, Tonelli M
    Measuring albuminuria or proteinuria: does one answer fit all?
    Kidney Int. 2023;104:904-909.
    >> Share

  93. CLEENDERS E, Koshy P, Van Loon E, Lagrou K, et al
    An observational cohort study of histological screening for BK polyomavirus nephropathy following viral replication in plasma.
    Kidney Int. 2023;104:1018-1034.
    >> Share

    October 2023
  94. HAYES WN, Laing E, Brown R, Silsby L, et al
    A pragmatic, open-label, randomized controlled trial of Plasma-Lyte-148 versus standard intravenous fluids in children receiving kidney transplants (PLUTO).
    Kidney Int. 2023 Oct 30:S0085-2538(23)00760-3. doi: 10.1016/j.kint.2023.
    >> Share

  95. BUDDE K, Rostaing L
    A first small step toward personalized immunosuppression.
    Kidney Int. 2023;104:652-654.
    >> Share

  96. BAILLY E, Macedo C, Ossart J, Louis K, et al
    Interleukin-21 promotes Type-1 activation and cytotoxicity of CD56(dim)CD16(bright) natural killer cells during kidney allograft antibody-mediated rejection showing a new link between adaptive and innate humoral allo-immunity.
    Kidney Int. 2023;104:707-723.
    >> Share

    August 2023
  97. EMMONS BR, Batal I, Radhakrishnan J, Husain SA, et al
    Age-related changes in nephrosclerosis in a multiethnic living kidney donor cohort.
    Kidney Int. 2023;104:394-397.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016